ArticleTranslational andrology and urology2025

Upper urinary tract urothelial carcinoma patients show better overall response rate than bladder cancer patients during enfortumab vedotin treatment following pembrolizumab.

Mamoru Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.